Walleye Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Walleye Capital's PACB Position: Q3 2026 in Review
Walleye Capital opened a new position in Pacific Biosciences (PACB) in Q3 2026: 409,259 shares worth $970K. The stake represents ﹤0.01% of the portfolio and ranks #3501 among its holdings. This is a return to the name: Walleye Capital previously reported a position in PACB as recently as Q4 2024.
Walleye Capital first reported a position in PACB in Q2 2020 and has held it in 11 quarters since. The position peaked at $3.56M in Q4 2024. 150 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Walleye Capital held 409,259 shares of Pacific Biosciences worth $970K as of Q3 2026.
- Pacific Biosciences was a new Walleye Capital position in Q3 2026.
- Pacific Biosciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #3501 holding.
- Walleye Capital first reported a position in Pacific Biosciences in Q2 2020 and has held it in 11 quarters since.
- Walleye Capital's Pacific Biosciences position peaked at $3.56M in Q4 2024.
- 150 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.